Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Meyerzyme is a digestive enzyme supplement developed and marketed by Meyer Organics. It is available in multiple formulations, including a liquid syrup and capsules, designed to assist in the mechanical breakdown of food components. The liquid formulation typically contains fungal diastase and pepsin, which facilitate the hydrolysis of complex carbohydrates and proteins, respectively. The capsule formulation provides a broader spectrum of enzymes, including amylase, protease, lipase, alpha-galactosidase, and hemicellulase, to aid in the digestion of fats, complex sugars, and plant fibers. Meyerzyme is primarily used as a digestive aid to treat symptoms of indigestion, flatulence, and abdominal discomfort associated with enzymatic insufficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Meyerzyme.